Prosetta picks up about $31 mln
San Francisco-based biotech company Prosetta Biosciences Inc has closed about $31 million in a Series D private placement. The investors included Alger Management and Takeda Pharmaceutical Company Limited. T.R. Winston & Company served as the placement agent and financial advisor to Prosetta in the transaction.
7 December 2015•3 mins read
